China News Service, Zhengzhou, January 11 (Li Mingming) Henan Provincial Health and Health Commission reported on the 11th that recently, the National Health Commission approved the construction of key laboratories jointly by six commissions and provinces, relying on the cerebrovascular construction of the First Affiliated Hospital of Zhengzhou University The key laboratory for disease prevention and control is among them.
This is the second key laboratory jointly established by the CPC and the province in Henan.
Cerebrovascular disease is a type of chronic disease that seriously threatens human life and health. It has the characteristics of high morbidity, high disability, high mortality, and high recurrence rate. It brings heavy medical and economic burdens to individuals, families and society.
With a population of over 100 million in Henan Province, the incidence and mortality of cerebrovascular diseases are among the highest in the country, and there are many high-risk groups of cerebrovascular diseases, and the prevention and treatment situation is severe.
The latest epidemiological survey shows that there are about 1.47 million stroke patients in Henan, the incidence rate of stroke is higher than 3/1000, the mortality rate is about 1.5/1000, 70% of the survivors are left with different degrees of disability, and the annual economic loss exceeds 10 billion. yuan.
The experience of developed countries shows that efficient health management and intervention can effectively reduce morbidity and mortality.
According to Xu Yuming, director of the Third Department of Neurology of the First Affiliated Hospital of Zhengzhou University, the key laboratory of cerebrovascular disease prevention and treatment integrates the branch of the National Neurological Disease Clinical Research Center, the construction unit of the Henan Provincial Cerebrovascular Disease Regional Medical Center, and the National Cardiovascular and Cerebrovascular Disease Difficulties Enhancement projects and many other platforms, focusing on “adopting risk assessment and intervention strategies for people at high risk of stroke, establishing multiple research cohorts for healthy people, people at high risk for stroke, small vessel disease, moyamoya disease, etc., to conduct stroke risk assessment and intervention, based on China’s national conditions and Epidemiological characteristics, build a cerebrovascular disease prevention and control network based in the community and primary medical institutions, guide primary prevention, and reduce the incidence of cerebrovascular disease; carry out the construction of stroke emergency treatment system and research on key technologies; adopt secondary stroke prevention risks Prediction and stratified intervention strategies, establish stroke prognostic prediction models and secondary prevention stratified intervention models suitable for the Chinese population, guide secondary prevention and health management after stroke, reduce stroke recurrence rate; adopt stroke rehabilitation and neural repair transformation Strategies, explore new technologies and methods in rehabilitation medicine, stem cells and other fields, and transform the role and mechanism in the repair and recovery of neurological deficits after stroke, realize clinical application, reduce the disability rate of stroke, and improve the quality of life of patients "Works such as this will narrow the gap between Henan's cerebrovascular disease clinical transformation strength and the international first-class level, and promote the continuous improvement of Henan's cerebrovascular disease prevention and treatment level.
(Finish)